Policy & Law

CMS-OMB Delaying Physician Disclosure Rule

1 Mins read

Don’t blame us, blame the Office of Management and Budget, officials at the Center for Medicare and Medicaid Services told Senators Charles Grassley (R-Ia.) and Herb Kohl (D-Wis.) last week. The senators had inquired why CMS missed the deadline for publishing a rule outlining how drug companies should comply with the Physician Payments Sunshine Act, which is supposed to go into effect on Jan. 1, 2013. Companies are supposed to begin collecting data on their payments to physicians starting Jan. 1, 2012, with public dissemination a year later.

Don’t blame us, blame the Office of Management and Budget, officials at the Center for Medicare and Medicaid Services told Senators Charles Grassley (R-Ia.) and Herb Kohl (D-Wis.) last week. The senators had inquired why CMS missed the deadline for publishing a rule outlining how drug companies should comply with the Physician Payments Sunshine Act, which is supposed to go into effect on Jan. 1, 2013. Companies are supposed to begin collecting data on their payments to physicians starting Jan. 1, 2012, with public dissemination a year later. But without final rules, many small companies will hang back, the two senators alleged in a letter sent to CMS yesterday, two days after the deadline for publishing the rule.

OMB needs to get the proposed rule out the door, and it needs to be closely scrutinized. The structure of the public database will largely determine the usefulness of this data. While many large companies are already disclosing their payments, they use different formats and the data is generally not searchable. If these company filings are simply dumped onto the web, it will become an onerous task for patients, consumer advocacy groups, researchers or anyone else to go through every filing looking for specific disclosures about individual physicians.

The rule must be quite specific as to the structure of the database, and require every company filing conform to its data requirements. The law was not intended to build a forest in which it becomes impossible to spot individual trees.

Related posts
Global HealthcarePolicy & Law

Do HMOs Deserve A Bad Reputation? The Truth Of Managed Healthcare

3 Mins read
Have you ever heard people say that HMO health insurance is no good? It’s no secret that HMOs have a bad reputation,…
Policy & Law

Top 4 Important Things To Understand About Insurance

2 Mins read
When it comes to Medicare, the enrollment process can be a little tricky. That’s why it’s important to understand the relevant health…
Health carePolicy & Law

Elmiron Controversy Highlights Need For Longterm Clinical Drug Testing

4 Mins read
Elmiron has recently been the subject of a number of lawsuits brought about over claims that the drug causes vision problems and may lead…